The Office of Academic Integration has awarded $750,000 in seed grants to 10 studies ranging from refugee health and legal rights, to a vaccine treating fentanyl addiction and overdose, to pancreatic cancer and antibiotic tolerance.
Gender Equality in Tech (GET) Cities, led by Cornell Tech-based Break Through Tech and SecondMuse, in partnership with Melinda Gates’ Pivotal Ventures, has launched GET DC as its next city hub.
In an expansion of its biomedical education curricula, Weill Cornell Medicine is launching an additional site for graduate programs at Houston Methodist for the 2021-22 academic year.
A new study identifies the mechanism for tolerance to penicillin and related antibiotics in bacteria, findings that could lead to new therapies that boost the effectiveness of these treatments.
Finding innovative solutions for cities’ most pressing problems is a primary goal of the new Urban Tech Hub, part of the Jacobs Technion-Cornell Institute at Cornell Tech.
The discovery of an “Achilles’ heel” in a type of gut bacteria that causes intestinal inflammation in patients with Crohn’s disease may lead to more targeted therapies for the difficult-to-treat disease, researchers have found.
The visiting critic discusses the importance of social design shaped by community partnerships, and a collaboration with AAP students and Black high schoolers in Brooklyn.
A type of cell widely used for brain research and drug development may have been leading researchers astray for years, according to a study from scientists at Weill Cornell Medicine and Columbia University.
Researchers at Weill Cornell Medicine and Cornell’s Ithaca campus have developed a new computational method for studying genetic and environmental interactions and how they influence disease risk.
